Clinical Presentation of Native Mitral Valve Infective Endocarditis Determines Long-Term Outcome after Surgery

2015 ◽  
Vol 30 (9) ◽  
pp. 669-676 ◽  
Author(s):  
Sigurdur Ragnarsson ◽  
Johan Sjögren ◽  
Martin Stagmo ◽  
Per Wierup ◽  
Shahab Nozohoor
Keyword(s):  
Infective Endocarditis ◽  
Mitral Valve ◽  
Clinical Presentation ◽  
Term Outcome ◽  
Long Term Outcome

Early and Long-term Outcome of Mitral Valve Repair for Native Mitral Valve Infective Endocarditis

2019 ◽  
Vol 3 (sup1) ◽  
pp. 83-83
Author(s):  
Chiho Tokunaga ◽  
Hiroyuki Nakajima ◽  
Daisuke Kaneyuki ◽  
Akitoshi Takazawa ◽  
Hiroaki Izumida ◽  
...  
Keyword(s):  
Infective Endocarditis ◽  
Mitral Valve ◽  
Mitral Valve Repair ◽  
Valve Repair ◽  
Term Outcome ◽  
Long Term Outcome

scholarly journals Long-term Outcome of Extensive Mitral Valve Reconstruction With Autologous Pericardium and Artificial Chordae for Treatment of Destructive Active Infective Endocarditis of the Mitral Valve

2021 ◽  
Author(s):  
Kazuma Handa ◽  
Takafumi Masai ◽  
Toshihiro Ohata ◽  
Tomohiko Sakamoto ◽  
Toru Kuratani
Keyword(s):  
Infective Endocarditis ◽  
Mitral Valve ◽  
Young Patients ◽  
Left Ventricular Ejection ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Autologous Pericardium ◽  
Valve Reconstruction ◽  
Artificial Chordae

Abstract Objective: Mitral valve (MV) repair is a well-accepted surgical approach for infective endocarditis (IE). In our hospital, extensive MV reconstruction with fresh autologous pericardium (AP) and artificial chordae (AC) has been performed for patients with profoundly extensive and destructive IE in which valve reconstruction would be extremely challenging, especially in young patients to avoid mechanical valve replacement. Long-term outcome including the future performance of the newly created leaflet has not been established. Methods: Five patients (50 ± 30 years of age; 3 men, 2 women) underwent this procedure from January 2011 to December 2020. In all patients, preoperative cardiac function was good (left ventricular ejection fraction, 70% ± 5%). After complete debridement of the infective valve tissue, the MV was reconstructed with large, fresh, trimmed AP and AC.Results: The reconstructed leaflets were anterior in three patients and posterior in four, and AC were placed in four patients. All patients showed an uneventful postoperative course and were discharged to home 35 ± 5 days postoperatively after completion of intravenous antibiotic therapy. Pre-discharge echocardiography revealed no or trivial mitral regurgitation (MR) in all patients. The mean follow-up period was 7.2 (range, 1.3–9.5) years, and no patients developed recurrence of the IE. The latest echocardiography in four patients showed trivial/mild MR with good leaflet function. One patient developed recurrence of MR, 5 months postoperatively. Conclusions: The short- and long-term outcomes of this procedure were satisfactory. This procedure might be considered as an effective and valuable option, especially in young patients.

scholarly journals Long-term outcome of extensive mitral valve reconstruction with autologous pericardium and artificial chordae for treatment of destructive active infective endocarditis of the mitral valve

2021 ◽  
Author(s):  
Kazuma Handa ◽  
Takafumi Masai ◽  
Toshihiro Ohata ◽  
Tomohiko Sakamoto ◽  
Yusuke Yanagino
Keyword(s):  
Infective Endocarditis ◽  
Mitral Valve ◽  
Young Patients ◽  
Left Ventricular Ejection ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Autologous Pericardium ◽  
Valve Reconstruction ◽  
Artificial Chordae

Background and aim: Mitral valve (MV) repair is a well-accepted surgical approach for infective endocarditis (IE). In our hospital, extensive MV reconstruction with fresh autologous pericardium (AP) and artificial chordae (AC) has been performed for patients with profoundly extensive and destructive IE in which valve reconstruction would be extremely challenging, especially in young patients to avoid mechanical valve replacement. Long-term outcome including the future performance of the newly created leaflet has not been established. Methods: Five patients (50 ± 30 years of age; 3 men, 2 women) underwent this procedure from January 2011 to December 2020. In all patients, preoperative cardiac function was good (left ventricular ejection fraction, 70% ± 5%). After complete debridement of the infective valve tissue, the MV was reconstructed with large, fresh, trimmed AP and AC. Results: The reconstructed leaflets were anterior in three patients and posterior in four, and AC were placed in four patients. All patients showed an uneventful postoperative course and were discharged to home 35 ± 5 days postoperatively after completion of intravenous antibiotic therapy. Pre-discharge echocardiography revealed no or trivial mitral regurgitation (MR) in all patients. The mean follow-up period was 7.2 (range, 1.3–9.5) years, and no patients developed recurrence of the IE. The latest echocardiography in four patients showed trivial/mild MR with good leaflet function. One patient developed recurrence of MR, 5 months postoperatively. Conclusions: The short- and long-term outcomes of this procedure were satisfactory. This procedure might be considered as an effective and valuable option, especially in young patients.

Long-Term Outcome of Mitral Valve Repair for Infective Endocarditis

2009 ◽  
Vol 88 (3) ◽  
pp. 733-739 ◽  
Author(s):  
Tomoki Shimokawa ◽  
Hitoshi Kasegawa ◽  
Shigefumi Matsuyama ◽  
Hiroshi Seki ◽  
Susumu Manabe ◽  
...  
Keyword(s):  
Infective Endocarditis ◽  
Mitral Valve ◽  
Mitral Valve Repair ◽  
Valve Repair ◽  
Term Outcome ◽  
Long Term Outcome

scholarly journals Long-term outcome in a case of translocated mitral valve replacement for massive mitral annular calcification

2017 ◽  
Vol 5 (4) ◽  
pp. 454-457
Author(s):  
Go Kataoka ◽  
Kiyoharu Nakano ◽  
Ryota Asano ◽  
Atsuhiko Sato ◽  
Wataru Tatsuishi
Keyword(s):  
Mitral Valve ◽  
Valve Replacement ◽  
Mitral Valve Replacement ◽  
Mitral Annular Calcification ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Annular Calcification

R15 Long-term Outcome Following Mitral Valve Repair in Rheumatic Heart Disease

2021 ◽  
Vol 30 ◽  
pp. S21-S22
Author(s):  
K.F.L. Lee ◽  
O.J.O.J. Lee ◽  
T.L.D. Chan ◽  
K.L.C. Ho ◽  
W.K.T. Au
Keyword(s):  
Heart Disease ◽  
Mitral Valve ◽  
Rheumatic Heart Disease ◽  
Mitral Valve Repair ◽  
Valve Repair ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Rheumatic Heart

Predictors of the Long-Term Outcome After Combined Aortic and Mitral Valve Surgery

Circulation ◽  
1999 ◽  
Vol 100 (Supplement 2) ◽  
pp. II-48-II-53 ◽  
Author(s):  
J. Turina ◽  
T. Stark ◽  
B. Seifert ◽  
M. Turina
Keyword(s):  
Mitral Valve ◽  
Mitral Valve Surgery ◽  
Valve Surgery ◽  
Term Outcome ◽  
Long Term Outcome

scholarly journals Long-term Outcome of Patients With Nonoperated Prosthetic Valve Infective Endocarditis: Is Relapse the Main Issue?

2019 ◽  
Vol 71 (5) ◽  
pp. 1316-1319 ◽  
Author(s):  
Raphaël Lecomte ◽  
Jean-Baptiste Laine ◽  
Nahéma Issa ◽  
Matthieu Revest ◽  
Benjamin Gaborit ◽  
...  
Keyword(s):  
Infective Endocarditis ◽  
Mortality Rate ◽  
Prosthetic Valve ◽  
Prosthetic Valve Endocarditis ◽  
Main Issue ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Risk Of Relapse

Abstract In nonoperated prosthetic valve endocarditis (PVE), long-term outcome is largely unknown. We report the follow-up of 129 nonoperated patients with PVE alive at discharge. At 1 year, the mortality rate was 24%; relapses and reinfection were rare (5% each). Enterococcal PVE was associated with a higher risk of relapse.

Sign in / Sign up

Export Citation Format

Share Document